Latest filing published 18 Mar 2025 for Zomedica Corp., €7,754.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +68.8%Entry US$0.08 · Close at T+365 US$0.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher Ross Macleod: trading record in brief
Christopher Ross Macleod appears in our data through filings on Zomedica Corp. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 3 February 2021 to 17 March 2025.
Market trades split into 1 purchase (€7,754) and 1 sale (€5,848). The net balance comes to €1,906 on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 1 purchase and no sales.
Most recently, on 18 March 2025, the filings show an open-market purchase worth €7,754 in Zomedica Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher Ross Macleod
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 143,000 shares@ US$0.059100.0% of flowCommon Stock, without par valueSEC:0001654954-25-002966:0Canonical exit: 15 Jun 2025 (T+90)
- 6,400 shares@ US$1.1043.0% of flowCommon Stock, without par valueSEC:0001171843-21-000778:0
2 of 2 declarations